Loading live market data…

FMC Corporation

NYSE:FMC

$10.83 USD

$0.11 (1.03%)

Volume
3.87M
Average Volume
3.77M
Market Capitalization
$1.35B
P/E Ratio
-0.54
Dividend Yield
7.57%
Price Target
$14.75
Year High
$43.97
Year Low
$10.56
Day High
Day Low
Payout Ratio
$-0.09
Current Ratio
$1.29
Source Headline
FMC Files First Global Regulatory Submission With EPA for Rimisoxafen

FMC's first global dossier for rimisoxafen seeks U.S. approval for a dual-action herbicide aimed at tough broadleaf weeds in major crops.

zacks.com - 2026-07-09 11:21:14

FMC Corporation Files First Global Regulatory Submission for Rimisoxafen with United States Environmental Protection Agency

The submission marks an important milestone in FMC's efforts to advance next-generation weed control technologies as resistance pressure intensifies in key row crop markets. PHILADELPHIA, July 8, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced it has submitted the regulatory dossier for rimisoxafen to the United States (U.S.) Environmental Protection Agency (EPA), the first regulatory submission globally for this groundbreaking herbicide active ingredient.

prnewswire.com - 2026-07-08 16:30:00

FMC Lands $400M Minority Investment From Tessenderlo Group

FMC secures a $400 million investment from Tessenderlo Group to cut debt, strengthen liquidity and support crop protection technology growth.

zacks.com - 2026-07-01 09:06:17

FMC Corporation Reaches Agreement for $400 Million Minority Equity Investment from Tessenderlo Group

FMC Corporation Reaches Agreement for $400 Million Minority Equity Investment from Tessenderlo Group PR Newswire

gurufocus.com - 2026-06-30 23:00:00

FMC Corporation Reaches Agreement for $400 Million Minority Equity Investment from Tessenderlo Group

Tessenderlo Group's investment reflects its strategy of making cornerstone minority investments in high-quality companies Investment enables FMC to achieve approximately $1 billion debt paydown target FMC concludes strategic options review FMC maintains focus on delivering on its operational and strategic plan PHILADELPHIA and BRUSSELS, June 30, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, and Tessenderlo Group (XBRU: TESB), a Belgian-based industrial group, today announced that they have entered into a definitive agreement under which Tessenderlo Group will make a strategic minority equity investment in FMC Corporation of approximately $400 million USD at a price of $13.30 per share. Upon completion of the transaction, Tessenderlo Group will own approximately 20.0% of the outstanding shares of FMC common stock.

prnewswire.com - 2026-06-30 22:05:00

FMC to Sell Newark Property for $114M, Use Proceeds to Cut Debt

FMC plans a $114M Newark property sale to cut debt, retain key R&D operations and keep its Stine Research Center fully intact.

zacks.com - 2026-06-24 10:31:19

FMC Corporation Announces $114 Million Sale-Leaseback of Newark, Delaware Property

Company will continue to operate its global R&D headquarters at the Stine Research Center PHILADELPHIA, June 23, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced that it has entered into a framework agreement to sell its property in Newark, Delaware for gross proceeds of approximately $114 million USD, subject to a due diligence period and other closing conditions and adjustments. Upon completion of the sale, FMC intends to lease back the facilities it actively operates under a separate lease agreement.

prnewswire.com - 2026-06-23 07:30:00

FMC Corporation announces date for second quarter 2026 earnings release and webcast conference call

PHILADELPHIA, June 22, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) announced today it will release its second quarter 2026 earnings on Wednesday, July 29, 2026, after the stock market close via PR Newswire and the company's website https://investors.fmc.com. The company will host a webcast conference call on Thursday, July 30, 2026, at 9:00 a.m.

prnewswire.com - 2026-06-22 16:30:00

FMC and Corteva Partner to Expand Access to Rimisoxafen Technology

FMC's rimisoxafen deal with Corteva aims to expand access to dual-mode herbicide technology for corn and soybean markets across the Americas.

zacks.com - 2026-06-18 13:11:07

FMC Corporation (FMC) Presents at 3rd Annual Materials of the Future Conference Transcript

FMC Corporation (FMC) Presents at 3rd Annual Materials of the Future Conference Transcript

seekingalpha.com - 2026-06-17 12:12:15

FMC Corporation and Corteva Expand Access to Breakthrough Rimisoxafen Herbicide Technology

Strategic supply and license agreement will accelerate access for North and South American corn and soybean growers PHILADELPHIA and INDIANAPOLIS, June 16, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) and Corteva, Inc. (NYSE: CTVA), two leading global agricultural science and innovation companies, today announced a co-exclusive strategic supply and license agreement that will expand access to FMC's rimisoxafen technology across North and South America corn and soybean markets, adding an important new tool to each company's respective herbicide portfolio. This collaboration will enable more growers across the Americas to control herbicide-resistant weeds, including Amaranthus species – the number one weed resistance challenge globally in soybeans and critical in cross-crop pressure in corn – with this groundbreaking dual mode of action herbicide technology.

prnewswire.com - 2026-06-16 17:00:00

FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at Wolfe Research 3rd Annual Materials of the Future Conference

PHILADELPHIA, June 10, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) today announced that Pierre Brondeau, FMC chairman, chief executive officer and president, and Andrew Sandifer, FMC executive vice president and chief financial officer, will speak at the Wolfe Research 3rd Annual Materials of the Future conference on June 17, 2026, at 9:15 a.m. Eastern Time.

prnewswire.com - 2026-06-10 16:30:00

FMC Corporation (FMC) Presents at 16th Annual Wells Fargo Industrials & Materials Conference Transcript

FMC Corporation (FMC) Presents at 16th Annual Wells Fargo Industrials & Materials Conference Transcript

seekingalpha.com - 2026-06-09 18:32:09

FMC (FMC) Down 11.8% Since Last Earnings Report: Can It Rebound?

FMC (FMC) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-05-29 12:31:25

FMC Corp. Just Agreed to Sell Its India Commercial Business. Here's What That Means for the Stock in 2026.

FMC sold an asset to pay down debt, but the company is by no means out of the woods.

fool.com - 2026-05-28 06:05:00

FMC Corporation CFO Andrew Sandifer to speak at 16th Annual Wells Fargo Industrials & Materials Conference

PHILADELPHIA, May 26, 2026 /PRNewswire/ --  FMC Corporation (NYSE: FMC) today announced that Andrew Sandifer, FMC executive vice president and chief financial officer, will speak at the 16th Annual Wells Fargo Industrials & Materials Conference on June 9, 2026, at 2:15 p.m. Central Time.

prnewswire.com - 2026-05-26 16:30:00

Why FMC Stock Was Sinking This Week

The company is issuing $1.2 billion in secured convertible senior notes. Much of the proceeds will be directed toward paying down other notes maturing in October.

fool.com - 2026-05-22 13:35:47

If You'd Invested in FMC Stock 5 Years Ago, Here's How Much You'd Have Today (Spoiler: It's Not Pretty)

The company's stock valuation looks attractive at recent levels. But revenue has been falling and the company is exploring some extreme options.

fool.com - 2026-05-15 08:01:00

FMC Corporation (FMC) Presents at 21st Annual Global Farm to Market Conference Transcript

FMC Corporation (FMC) Presents at 21st Annual Global Farm to Market Conference Transcript

seekingalpha.com - 2026-05-14 16:50:50

FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at BMO Global Farm to Market Chemicals Conference

PHILADELPHIA, May 11, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) today announced that Pierre Brondeau, FMC chairman, chief executive officer and president, and Andrew Sandifer, FMC executive vice president and chief financial officer, will speak at the BMO Global Farm to Market Chemicals Conference on May 14, 2026, at 1:15 p.m. Eastern Time.

prnewswire.com - 2026-05-11 07:30:00

FMC Corporation Announces Agreement to Divest India Commercial Business to Crystal Crop Protection Limited

PHILADELPHIA, May 7, 2026 /PRNewswire/ -- FMC Corporation (NYSE:FMC), a leading global agricultural sciences company, announced today it has signed a definitive agreement to sell FMC India Private Limited (FMC India) to Crystal Crop Protection Limited, a crop solutions company in India, for consideration of $252 million USD, subject to customary adjustments for cash, debt and working capital. FMC will continue to receive all cash generated from the ongoing operation of the India business until closing, primarily through monetization of working capital.

prnewswire.com - 2026-05-07 07:30:00

FMC Analysts Boost Their Forecasts Following Better-Than-Expected Q2 Results

FMC Corp (NYSE:FMC) reported better-than-expected second-quarter financial results and reaffirmed its FY2026 guidance, after the closing bell on Wednesday.

benzinga.com - 2026-05-01 15:52:16

FMC Corporation (FMC) Q1 2026 Earnings Call Transcript

FMC Corporation (FMC) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-04-30 19:41:40

FMC Q1 Earnings Beat Estimates on Volume Gains and FX Tailwind

FMC beat Q1 revenue and loss estimates as volume gains and FX tailwinds offset pricing pressure, while it reaffirmed its 2026 outlook.

zacks.com - 2026-04-30 14:35:24

FMC (FMC) Reports Q1 Loss, Beats Revenue Estimates

FMC (FMC) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to earnings of $0.18 per share a year ago.

zacks.com - 2026-04-29 19:41:54

FMC Corporation reports first quarter 2026 results above guidance with Adjusted EBITDA above high end of range, reaffirms full-year outlook

Company continues to advance operational priorities and explore strategic options in parallel First Quarter 2026 Highlights Revenue of $759 million, down 4 percent versus Q1 2025 Revenue excluding India1 of $762 million, down 4 percent versus Q1 2025 (which included India) Organic revenue2 for the period declined 9 percent Consolidated GAAP net loss of $281 million, a decline of $266 million versus Q1 2025 Adjusted EBITDA of $72 million, down 40 percent versus Q1 2025 Consolidated GAAP loss of $2.25 per diluted share, down $2.13 versus Q1 2025 Adjusted loss per diluted share of $0.23, down 41 cents versus Q1 2025 Maintains 2026 Full-Year Outlook 1 Revenue excluding India of $3.60 billion to $3.80 billion, a decline of 5 percent at the midpoint versus 2025 Excluding 2025 India contributions, the 2026 outlook represents a decline at the midpoint of 3 percent Adjusted EBITDA of $670 million to $730 million, a decline of 17 percent at the midpoint Adjusted earnings per diluted share of $1.63 to $1.89, a decline of 41 percent at the midpoint Free cash flow of negative $65 million to $65 million, an improvement of $165 million at the midpoint PHILADELPHIA, April 29, 2026 /PRNewswire/ -- FMC Corporation (NYSE:FMC) today reported first quarter 2026 revenue of $759 million, down 4 percent versus first quarter 2025.  First quarter 2026 revenue, excluding India, was $762 million, down 4 percent versus first quarter 2025, which included India.

prnewswire.com - 2026-04-29 16:30:00

FMC Corporation Declares Quarterly Dividend

PHILADELPHIA, April 28, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) announced today that its board of directors declared a regular quarterly dividend of 8 cents per share, payable on July 16, 2026, to shareholders of record as of the close of business on June 30, 2026.    About FMC FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment.

prnewswire.com - 2026-04-28 16:30:00

FMC (FMC) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

FMC (FMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-04-22 11:02:34

Why This $4.4 Million Exit Looks Bearish for a Chemicals Stock Down 50%

Old North State sold all its 295,829 FMC shares in the first quarter, estimated at $4.42 million based on quarterly average prices. Meanwhile, the quarter-end position value decreased by $4.10 million, reflecting both trading and share price changes.

fool.com - 2026-04-17 12:27:35

Alpha FMC appoints new Senior Partner to lead global SimCorp partnership

NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- Alpha FMC (“Alpha”), a leading global consultancy to the financial services industry, today announces the appointment of Zoe Kohli as Senior Partner, Global Partner Executive in its Asset & Wealth Management practice.

globenewswire.com - 2026-04-16 08:03:00

Get FMC Insider Trade Alerts

FMC Price Target Summary

Last Month

$15.00

2 analysts

Last Quarter

$15.67

3 analysts

Last Year

$20.98

22 analysts

All Time

$66.07

52 analysts

FMC Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-06-22 Citigroup Maintain Neutral Neutral
2026-05-01 RBC Capital Maintain Sector Perform Sector Perform
2026-05-01 JP Morgan Maintain Neutral Neutral
2026-05-01 Citigroup Maintain Neutral Neutral
2026-04-24 RBC Capital Maintain Sector Perform Sector Perform
2026-04-21 Wells Fargo Maintain Equal Weight Equal Weight
2026-04-14 Goldman Sachs Maintain Buy Buy
2026-04-09 UBS Maintain Neutral Neutral
2026-02-17 Mizuho Maintain Outperform Outperform
2026-02-09 Citigroup Maintain Neutral Neutral
2026-02-06 RBC Capital Maintain Sector Perform Sector Perform
2026-02-06 Wells Fargo Maintain Equal Weight Equal Weight
2026-01-21 Citigroup Maintain Neutral Neutral
2026-01-16 Mizuho Maintain Outperform Outperform
2026-01-12 UBS Maintain Neutral Neutral
2025-12-18 Citigroup Maintain Neutral Neutral
2025-12-15 Mizuho Maintain Outperform Outperform
2025-12-09 Barclays Downgrade Equal Weight Underweight
2025-11-17 JP Morgan Maintain Neutral Neutral
2025-11-13 Barclays Maintain Equal Weight Equal Weight
2025-11-03 Morgan Stanley Maintain Equal Weight Equal Weight
2025-11-03 Goldman Sachs Maintain Buy Buy
2025-10-31 Wells Fargo Downgrade Overweight Equal Weight
2025-10-31 Citigroup Maintain Neutral Neutral
2025-10-31 RBC Capital Maintain Sector Perform Sector Perform
2025-10-31 UBS Maintain Neutral Neutral
2025-10-31 Keybanc Downgrade Overweight Sector Weight
2025-10-30 Barclays Downgrade Overweight Equal Weight
2025-10-22 Morgan Stanley Maintain Equal Weight Equal Weight
2025-10-22 Goldman Sachs Maintain Buy Buy
2025-10-16 Wells Fargo Maintain Overweight Overweight
2025-10-14 B of A Securities Upgrade Underperform Neutral
2025-10-09 Mizuho Maintain Outperform Outperform
2025-10-06 UBS Maintain Neutral Neutral
2025-10-06 Citigroup Maintain Neutral Neutral
2025-08-13 Barclays Maintain Overweight Overweight
2025-08-01 RBC Capital Maintain Sector Perform Sector Perform
2025-08-01 Morgan Stanley Maintain Equal Weight Equal Weight
2025-07-31 UBS Maintain Neutral Neutral
2025-07-14 Keybanc Maintain Overweight Overweight
2025-07-10 RBC Capital Maintain Sector Perform Sector Perform
2025-07-09 UBS Maintain Neutral Neutral
2025-07-07 Barclays Maintain Overweight Overweight
2025-06-23 Wells Fargo Upgrade Equal Weight Overweight
2025-05-02 Keybanc Maintain Overweight Overweight
2025-05-01 UBS Maintain Neutral Neutral
2025-04-21 Wells Fargo Maintain Equal Weight Equal Weight
2025-04-14 Keybanc Maintain Overweight Overweight
2025-03-05 Seaport Global Maintain Buy Buy
2025-02-18 Keybanc Maintain Overweight Overweight
2025-02-07 Barclays Maintain Overweight Overweight
2025-02-07 UBS Downgrade Buy Neutral
2025-02-05 B of A Securities Downgrade Neutral Underperform
2025-02-05 RBC Capital Downgrade Outperform Sector Perform
2025-02-05 Morgan Stanley Maintain Equal Weight Equal Weight
2025-02-05 BMO Capital Maintain Market Perform Market Perform
2025-01-29 Citigroup Maintain Neutral Neutral
2025-01-21 Barclays Upgrade Equal Weight Overweight
2025-01-14 B of A Securities Upgrade Underperform Neutral
2025-01-07 Mizuho Maintain Neutral Neutral
2025-01-02 Keybanc Maintain Overweight Overweight
2024-12-20 UBS Maintain Buy Buy
2024-12-18 Citigroup Maintain Neutral Neutral
2024-11-01 Mizuho Maintain Neutral Neutral
2024-11-01 RBC Capital Maintain Outperform Outperform
2024-08-12 JP Morgan Maintain Neutral Neutral
2024-08-05 Barclays Maintain Equal Weight Equal Weight
2024-08-02 BMO Capital Maintain Market Perform Market Perform
2024-08-02 Keybanc Maintain Overweight Overweight
2024-07-16 Wells Fargo Maintain Equal Weight Equal Weight
2024-05-13 JP Morgan Maintain Neutral Neutral
2024-05-10 RBC Capital Maintain Outperform Outperform
2024-05-08 Wells Fargo Maintain Equal Weight Equal Weight
2024-05-08 Keybanc Maintain Overweight Overweight
2024-05-07 Mizuho Maintain Neutral Neutral
2024-04-09 Keybanc Maintain Overweight Overweight
2024-03-20 UBS Upgrade Neutral Buy
2024-03-19 Loop Capital Maintain Hold Hold
2024-02-12 Loop Capital Downgrade Buy Hold
2024-02-08 RBC Capital Maintain Outperform Outperform
2024-02-07 BMO Capital Maintain Market Perform Market Perform
2024-02-07 Keybanc Maintain Overweight Overweight
2024-02-07 Exane BNP Paribas Downgrade Outperform Neutral
2024-02-06 Mizuho Maintain Neutral Neutral
2024-01-16 B of A Securities Downgrade Neutral Underperform
2024-01-11 UBS Maintain Neutral Neutral
2024-01-09 Keybanc Maintain Overweight Overweight
2023-12-14 BMO Capital Downgrade Outperform Market Perform
2023-12-07 Mizuho Downgrade Buy Neutral
2023-11-17 RBC Capital Maintain Outperform Outperform
2023-11-17 UBS Maintain Neutral Neutral
2023-11-02 RBC Capital Maintain Outperform Outperform
2023-10-24 B of A Securities Downgrade Buy Neutral
2023-10-24 Keybanc Maintain Overweight Overweight
2023-10-24 BMO Capital Maintain Outperform Outperform
2023-10-24 RBC Capital Maintain Outperform Outperform
2023-10-24 Morgan Stanley Downgrade Overweight Equal Weight
2023-10-24 Goldman Sachs Downgrade Buy Neutral
2023-10-24 Fermium Research Maintain Hold Hold
2023-10-23 Wells Fargo Maintain Equal Weight Equal Weight
2023-10-16 Vertical Research Upgrade Hold Buy
2023-10-10 Mizuho Maintain Buy Buy
2023-10-03 Keybanc Maintain Overweight Overweight
2023-09-25 RBC Capital Maintain Outperform Outperform
2023-09-25 Redburn Atlantic Downgrade Buy Neutral
2023-09-11 Morgan Stanley Maintain Overweight Overweight
2023-09-05 UBS Downgrade Buy Neutral
2023-08-04 Credit Suisse Upgrade Underperform Neutral
2023-08-04 Keybanc Maintain Overweight Overweight
2023-08-04 Mizuho Maintain Buy Buy
2023-07-24 Wells Fargo Downgrade Overweight Equal Weight
2023-07-12 Morgan Stanley Maintain Overweight Overweight
2023-07-12 B of A Securities Maintain Buy Buy
2023-07-11 Morgan Stanley Maintain Overweight Overweight
2023-07-11 RBC Capital Maintain Outperform Outperform
2023-07-11 Loop Capital Maintain Buy Buy
2023-07-11 Mizuho Maintain Buy Buy
2023-07-11 BMO Capital Maintain Outperform Outperform
2023-07-11 Keybanc Maintain Overweight Overweight
2023-07-11 Credit Suisse Maintain Underperform Underperform
2023-07-10 Fermium Research Maintain Hold Hold
2023-07-07 Morgan Stanley Maintain Overweight Overweight
2023-05-04 RBC Capital Maintain Outperform Outperform
2023-05-03 Wells Fargo Maintain Overweight Overweight
2023-05-03 Mizuho Maintain Buy Buy
2023-04-21 Mizuho Maintain Buy Buy
2023-03-17 Redburn Partners Upgrade Neutral Buy
2023-02-15 Goldman Sachs Maintain Buy Buy
2023-02-10 RBC Capital Maintain Outperform Outperform
2023-02-09 BMO Capital Maintain Outperform Outperform
2023-02-09 Keybanc Maintain Overweight Overweight
2023-02-08 Credit Suisse Maintain Underperform Underperform
2023-02-08 Mizuho Maintain Buy Buy
2023-01-20 Citigroup Maintain Buy Buy
2023-01-12 Mizuho Maintain Buy Buy
2023-01-12 Keybanc Maintain Overweight Overweight
2023-01-11 UBS Maintain Buy Buy
2023-01-10 Morgan Stanley Upgrade Equal Weight Overweight
2023-01-09 Wells Fargo Maintain Overweight Overweight
2022-11-15 Loop Capital Upgrade Hold Buy
2022-11-04 RBC Capital Maintain Outperform Outperform
2022-11-03 Keybanc Maintain Overweight Overweight
2022-11-02 Credit Suisse Maintain Underperform Underperform
2022-08-04 Mizuho Maintain Buy Buy
2022-08-03 Credit Suisse Maintain Underperform Underperform
2022-07-29 Mizuho Maintain Buy Buy
2022-07-20 Keybanc Upgrade Sector Weight Overweight
2022-07-13 UBS Maintain Buy Buy
2022-06-21 B of A Securities Upgrade Underperform Buy
2022-06-13 Redburn Partners Downgrade Buy Neutral
2022-05-31 Credit Suisse Maintain Underperform Underperform
2022-05-04 Wells Fargo Maintain Overweight Overweight
2022-04-29 Mizuho Maintain Buy Buy
2022-04-14 Loop Capital Downgrade Buy Hold
2022-04-06 Wells Fargo Maintain Overweight Overweight
2022-03-31 Monness, Crespi, Hardt Downgrade Buy Neutral
2022-03-22 Citigroup Maintain Buy Buy
2022-03-22 B of A Securities Downgrade Buy Underperform
2022-02-11 Morgan Stanley Maintain Equal Weight Equal Weight
2022-02-10 Mizuho Maintain Buy Buy
2022-02-10 Wells Fargo Maintain Overweight Overweight
2022-01-31 Redburn Partners Maintain Buy Buy
2022-01-11 Morgan Stanley Maintain Equal Weight Equal Weight
2022-01-04 UBS Maintain Buy Buy
2021-11-29 B of A Securities Upgrade Neutral Buy
2021-11-05 RBC Capital Maintain Outperform Outperform
2021-11-04 Mizuho Maintain Buy Buy
2021-10-13 Mizuho Maintain Buy Buy
2021-10-11 Keybanc Downgrade Overweight Sector Weight
2021-08-05 Citigroup Maintain Neutral Neutral
2021-08-05 Keybanc Maintain Overweight Overweight
2021-07-20 Loop Capital Downgrade Buy Hold
2021-06-24 Vertical Research Downgrade Buy Hold
2021-05-13 Wells Fargo Maintain Overweight Overweight
2021-05-07 Keybanc Maintain Overweight Overweight
2021-05-06 Citigroup Downgrade Buy Neutral
2021-02-11 KeyBanc Maintain Overweight Overweight
2021-02-11 Keybanc Maintain Overweight Overweight
2021-02-11 Credit Suisse Maintain Outperform Outperform
2021-02-10 KeyBanc Maintain Overweight Overweight
2020-12-14 Morgan Stanley Maintain Equal Weight Equal Weight
2020-11-25 UBS Maintain Buy Buy
2020-11-18 KeyBanc Maintain Overweight Overweight
2020-11-18 Keybanc Maintain Overweight Overweight
2020-11-04 Keybanc Maintain Overweight Overweight
2020-11-04 Credit Suisse Maintain Outperform Outperform
2020-11-04 KeyBanc Maintain Overweight Overweight
2020-09-17 UBS Maintain Buy Buy
2020-08-17 Morgan Stanley Maintain Equal Weight Equal Weight
2020-08-06 Credit Suisse Maintain Outperform Outperform
2020-08-06 Wells Fargo Maintain Overweight Overweight
2020-08-06 Citigroup Maintain Buy Buy
2020-07-13 Keybanc Maintain Overweight Overweight
2020-07-13 KeyBanc Maintain Overweight Overweight
2020-06-02 Morgan Stanley Maintain Equal Weight Equal Weight
2020-05-07 Baird Maintain Outperform Outperform
2020-05-07 KeyBanc Maintain Overweight Overweight
2020-05-07 Citigroup Maintain Buy Buy
2020-05-07 Keybanc Maintain Overweight Overweight
2020-05-06 CFRA Maintain Buy Buy
2020-04-17 Credit Suisse Maintain Outperform Outperform
2020-04-09 Citigroup Maintain Buy Buy
2020-04-06 SunTrust Robinson Humphrey Maintain Buy Buy
2020-04-03 Wells Fargo Maintain Overweight Overweight
2020-03-30 Morgan Stanley Maintain Equal Weight Equal Weight
2020-03-26 KeyBanc Maintain Overweight Overweight
2020-03-20 Stephens & Co. Maintain Overweight Overweight
2020-02-10 Susquehanna Maintain Positive Positive
2020-02-10 Morgan Stanley Maintain Equal Weight Equal Weight
2020-02-10 SunTrust Robinson Humphrey Maintain Buy Buy
2020-02-07 Wells Fargo Maintain Overweight Overweight
2020-01-15 Wells Fargo Maintain Overweight Overweight
2019-12-09 SunTrust Robinson Humphrey Maintain Buy Buy
2019-10-31 Wells Fargo Maintain Outperform Outperform
2019-10-31 Buckingham Maintain Buy Buy
2019-10-31 Buckingham Research Maintain Buy Buy
2019-10-16 Baird Upgrade Neutral Outperform
2019-10-16 Wells Fargo Maintain Outperform Outperform
2019-08-09 RBC Capital Upgrade Sector Perform Outperform
2019-08-02 Goldman Sachs Upgrade Neutral Buy
2019-08-01 Bank of America Downgrade Buy Neutral
2019-08-01 Nomura Maintain Buy Buy
2019-08-01 Credit Suisse Maintain Outperform Outperform
2019-08-01 B of A Securities Downgrade Buy Neutral
2019-08-01 Buckingham Research Maintain Buy Buy
2019-05-20 Morgan Stanley Maintain Equal Weight Equal Weight
2019-04-18 RBC Capital Downgrade Outperform Sector Perform
2019-04-12 Keybanc Maintain Overweight Overweight
2019-04-12 KeyBanc Maintain Overweight Overweight
2019-03-01 Credit Suisse Maintain Outperform Outperform
2019-02-14 Keybanc Maintain Buy Buy
2019-02-14 KeyBanc Maintain Buy Buy
2019-02-13 Credit Suisse Maintain Outperform Outperform
2019-02-13 Nomura Maintain Buy Buy
2018-12-04 Credit Suisse Maintain Outperform Outperform
2018-11-14 Buckingham Maintain Buy Buy
2018-11-06 Citigroup Maintain Buy Buy
2018-07-11 Nomura Maintain Buy Buy
2018-05-14 Goldman Sachs Upgrade Neutral Buy
2018-05-04 Bank of America Maintain Buy Buy
2018-05-04 Stephens & Co. Upgrade Equal Weight Overweight
2018-05-04 BMO Capital Maintain Outperform Outperform
2018-05-04 B of A Securities Maintain Buy Buy
2018-05-04 Credit Suisse Maintain Outperform Outperform
2018-04-12 BMO Capital Upgrade Market Perform Outperform
2018-02-15 Seaport Global Upgrade Neutral Buy
2018-02-14 Credit Suisse Maintain Outperform Outperform
2018-02-14 Citigroup Upgrade Neutral Buy
2017-12-05 Stephens & Co. Maintain Equal Weight Equal Weight
2017-11-13 Citigroup Maintain Neutral Neutral
2017-11-08 Keybanc Maintain Buy Buy
2017-11-08 BMO Capital Maintain Market Perform Market Perform
2017-11-08 Credit Suisse Maintain Outperform Outperform
2017-11-08 Bank of America Maintain Buy Buy
2017-11-08 KeyBanc Maintain Buy Buy
2017-11-08 B of A Securities Maintain Buy Buy
2017-11-08 Nomura Maintain Buy Buy
2017-10-16 Keybanc Maintain Buy Buy
2017-10-16 KeyBanc Maintain Buy Buy
2017-09-29 Loop Capital Maintain Buy Buy
2017-08-31 B of A Securities Upgrade Underperform Buy
2017-08-31 Bank of America Upgrade Underperform Buy
2017-08-04 Nomura Upgrade Neutral Buy
2017-08-03 BMO Capital Maintain Market Perform Market Perform
2017-07-18 Seaport Global Downgrade Buy Neutral
2017-05-15 Wells Fargo Upgrade Market Perform Outperform
2017-04-03 SunTrust Robinson Humphrey Upgrade Hold Buy
2017-04-03 Susquehanna Upgrade Neutral Positive
2017-03-23 Baird Maintain Neutral Neutral
2017-02-23 RBC Capital Maintain Outperform Outperform
2017-02-08 Longbow Research Upgrade Neutral Buy
2016-12-12 Goldman Sachs Upgrade Neutral Buy
2016-11-28 PiperJaffray Upgrade Underweight Neutral
2016-11-28 Piper Sandler Upgrade Underweight Neutral
2016-11-04 Credit Suisse Upgrade Neutral Outperform
2016-08-26 Susquehanna Maintain Neutral Neutral
2016-07-15 Citigroup Maintain Neutral Neutral
2016-04-21 Credit Suisse Downgrade Outperform Neutral
2016-04-15 CLSA Maintain Outperform Outperform
2016-03-18 BMO Capital Maintain Market Perform Perform
2016-02-16 SunTrust Robinson Humphrey Maintain Neutral Neutral
2016-01-22 Credit Suisse Maintain Outperform Outperform
2016-01-04 Piper Sandler Downgrade Neutral Underweight
2016-01-04 PiperJaffray Downgrade Neutral Underweight
2015-11-20 Citigroup Maintain Neutral Neutral
2015-10-14 Macquarie Maintain Neutral Neutral
2015-09-23 Jefferies Maintain Buy Buy
2015-09-18 Cowen & Co. Upgrade Market Perform Outperform
2015-08-28 Longbow Research Downgrade Buy Neutral
2015-08-12 SunTrust Robinson Humphrey Maintain Neutral Neutral
2015-06-04 Seaport Global Maintain Accumulate Buy
2015-04-20 Monness Crespi Hardt Maintain Neutral Neutral
2015-02-10 Vertical Research Downgrade Buy Hold
2015-02-10 Jefferies Maintain Hold Hold
2014-12-16 Nomura Maintain Neutral Neutral
2014-10-16 ISI Group Maintain Buy Buy
2014-10-15 Jefferies Maintain Hold Hold
2014-10-07 Jefferies Maintain Hold Hold
2014-10-01 KeyBanc Maintain Buy Buy
2014-10-01 Keybanc Maintain Buy Buy
2014-08-15 Edward Jones Upgrade Hold Buy
2014-08-04 Jefferies Maintain Hold Hold
2014-07-24 JP Morgan Maintain Overweight Overweight
2014-07-14 Jefferies Downgrade Buy Hold
2014-06-24 KeyBanc Maintain Buy Buy
2014-06-24 Credit Suisse Maintain Outperform Outperform
2014-06-24 Keybanc Maintain Buy Buy
2014-05-23 Jefferies Maintain Buy Buy
2014-03-17 Macquarie Downgrade Outperform Neutral
2014-03-13 B of A Securities Maintain Neutral Neutral
2014-03-13 Bank of America Maintain Neutral Neutral
2014-03-11 PiperJaffray Downgrade Overweight Neutral
2014-03-11 Piper Sandler Downgrade Overweight Neutral
2014-03-11 Wells Fargo Downgrade Outperform Perform
2014-03-10 Wells Fargo Downgrade Outperform Market Perform
2014-01-15 Longbow Research Upgrade Neutral Buy
2013-08-27 PiperJaffray Maintain Overweight Overweight
2013-07-08 Goldman Sachs Downgrade Neutral Sell
2013-06-04 Credit Suisse Maintain Outperform Outperform
2013-04-08 Macquarie Upgrade Neutral Outperform
2013-02-11 Jefferies Maintain Buy Buy
2012-12-12 Goldman Sachs Maintain Neutral Neutral
2012-10-25 UBS Maintain Buy Buy
2012-09-28 Bank of America Downgrade Buy Neutral
2012-09-28 B of A Securities Downgrade Buy Neutral
2012-09-19 Goldman Sachs Maintain Neutral Neutral
2012-09-10 Jefferies Maintain Buy Buy
2012-05-02 Jefferies Maintain Buy Buy
2012-02-27 Jefferies Maintain Buy Buy
2012-02-17 Societe Generale Maintain Hold Hold